NCT00548184View on ClinicalTrials.gov

Lapatinib and Trastuzumab With or Without Endocrine Therapy

PHASE2CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2014

Conditions
Breast Cancer
Interventions
DRUG

Lapatinib

Monoclonal Antibody

DRUG

Trastuzumab

Monoclonal Antibody

DRUG

Endocrine

Hormonal Therapy

Trial Locations (6)

35294

UAB Cancer Center, Birmingham

55905

Mayo Clinic Cancer Center, Rochester

60637

The University of Chicago, Chicago

77030

Baylor College of Medicine, Lester and Sue Smith Breast Center, Houston

21231-1000

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Bunting-Blaustein Cancer Research, Baltimore

37232-6868

Vanderbilt-Ingram Cancer Center, Nashville

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

Baylor Breast Care Center

OTHER